Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort

Autor: Marina Backhaus, Ori Elkayam, J. Carter Thorne, Gianfranco Ferraccioli, Paul P. Tak, Mikkel Østergaard, M. Govoni, Joanne Homik, Clifton O. Bingham, Walter P. Maksymowych, Hilde Berner Hammer, Dirkjan van Schaardenburg, Alexandre Sepriano, Maxime Dougados, Joel Paschke, Désirée van der Heijde, Sofia Ramiro, Robert Landewé, Alain Cantagrel, Alain Saraux, Cheryl Barnabe, Oliver FitzGerald, Maggie Larché, Luigi Sinigaglia, E. Hutchings, Maurizio Rossini, Thierry Schaeverbeke, Gerd R Burmester, Bernard Combe, Gilles Boire, R. Dadashova

Publikováno v: Journal of Rheumatology
Journal of Rheumatology, 2020, 47 (6), pp.809-819. ⟨10.3899/jrheum.190303⟩
Journal of Rheumatology, Journal of Rheumatology Publishing Company Limited, 2020, 47 (6), pp.809-819. ⟨10.3899/jrheum.190303⟩
Journal of rheumatology, 47(6), 809-819. Journal of Rheumatology
The Journal of Rheumatology, 47(6), 809-819. J RHEUMATOL PUBL CO

Objective.Compelling evidence supports a treat-to-target (T2T) strategy for optimal outcomes in rheumatoid arthritis (RA). There is limited knowledge regarding the factors that impede implementation of T2T, particularly in a setting where adherence t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc6ea9f1ed50ce08f5a77275b0c3b340
https://hal.umontpellier.fr/hal-03365499

Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)

Autor: Joel Paschke, Sofia Ramiro, E. Hutchings, Cheryl Barnabe, Dirkjan van Schaardenburg, Thierry Schaeverbeke, Alexandre Sepriano, Désirée van der Heijde, Bernard Combe, Robert Landewé, Marina Backhaus, Maurizio Rossini, Margaret Larche, Joanne Homik, Marcello Govoni, Walter P. Maksymowych, Cornelia F Allaart, Ori Elkayam, Clifton O. Bingham, Alain Saraux, J. Carter Thorne, Oliver FitzGerald, Luigi Sinigaglia, Gilles Boire, Hilde Berner Hammer, R. Dadashova, Gianfranco Ferraciolli, Paul P. Tak, Maxime Dougados, Alain Cantagrel, Mikkel Østergaard

Publikováno v: Annals of the rheumatic diseases, 79(4), 453-459. BMJ Publishing Group
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2020, 79 (4), pp.453-459. ⟨10.1136/annrheumdis-2019-216819⟩
Annals of the Rheumatic Diseases, 79(4), 453-459. BMJ PUBLISHING GROUP

ObjectivesTo investigate whether following a treat-to-target (T2T)-strategy in daily clinical practice leads to more patients with rheumatoid arthritis (RA) meeting the remission target.MethodsRA patients from 10 countries starting/changing conventio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6c1e8609fe7bae4137c41b435d44503
http://hdl.handle.net/11392/2420106

Granulome central à cellules géantes de l’enfant : présentation des différentes options thérapeutiques

Autor: M. Longeac, N. Pham Dang, M. Picard, Isabelle Barthélémy, Laurent Devoize

Publikováno v: Revue de Stomatologie, de Chirurgie Maxillo-faciale et de Chirurgie Orale
Revue de Stomatologie, de Chirurgie Maxillo-faciale et de Chirurgie Orale, Société Française de Stomatologie Chirurgie Maxillo-faciale et de Chirurgie Orale (SFSCMFCO) / Elsevier, 2016, 117 (3), pp.142-146. ⟨10.1016/j.revsto.2016.01.007⟩

International audience; Central giant cell granuloma (CGCG) is a benign tumor that may be subdivided in a non-aggressive form and an aggressive form. In aggressive forms, tumor size and high recurrence risk need large surgical resections. In order to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07a18b67f1846ae26e078d969e331f96
https://doi.org/10.1016/j.revsto.2016.01.007

Utilisation en pratique du rituximab en 2nde ligne et au-delà dans le traitement du pemphigus: série rétrospective

Autor: Barroil, M., Girard, C., Lerisson, M., Negroni, V., Bertrand, A.-S., Pallure, V., Bessis, D., Guillot, B., Dereure, O.

Publikováno v: Annales de Dermatologie et de Vénéréologie
Annales de Dermatologie et de Vénéréologie, Elsevier Masson, 2020, 147 (3), pp.173-178. ⟨10.1016/j.annder.2019.08.020⟩

International audience; Rituximab (RTX), currently recommended as first-line treatment in moderate to severe pemphigus vulgaris (PV) and superficial pemphigus (PS) along with initial systemic steroids, may also be used as second-line or subsequent tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::62288e468a41686eed906cf1fd302dc2
https://pubmed.ncbi.nlm.nih.gov/31955970

Prognostic Factors for Leukemic Induction Failure in Children With Acute Lymphoblastic Leukemia and Outcome After Salvage Therapy: The FRALLE 93 Study

Autor: Claudine Schmitt, Marie-Françoise Auclerc, Jean-Michel Cayuela, Gérard Michel, André Baruchel, Guy Leverger, Marianne Debré, Yves Perel, Brigitte Pautard, Thierry Leblanc, Gérard Socié, Raphaël Porcher, Caroline Oudot, Christophe Piguet, Virginie Gandemer, Vincent Levy, Claire Berger, Christiane Vermylen

Publikováno v: Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2008, 26 (9), pp.1496-503. ⟨10.1200/JCO.2007.12.2820⟩
Journal of Clinical Oncology, 2008, 26 (9), pp.1496-503. ⟨10.1200/JCO.2007.12.2820⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2008, 26 (9), pp.1496-503. 〈10.1200/JCO.2007.12.2820〉

Purpose To identify prognostic factors and to evaluate the outcome of children with acute lymphoblastic leukemia (ALL) failure after induction therapy. Patients and Methods Between June 1993 and December 1999, 1,395 leukemic children were included in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a4a147552ddeb2bd5ffdfcf748dc8f4
https://doi.org/10.1200/jco.2007.12.2820